Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Withdrawn 1Completed 1

Sponsor Class

OTHER 2NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 16Gastrointestinal 11Other hematologic neoplasm 10Lymphoid 9Thoracic 8Sarcoma 7Plasma cell 7CNS 7Gynecologic 5Genitourinary 5Dermatologic 5Classical hematology 3Myeloid 2Other neoplasm 1Other 1

Conditions

Myelodysplastic Syndromes 999Leukemia, Myeloid, Acute 826Leukemia, Myelogenous, Chronic, BCR-ABL Positive 532Leukemia 519Precursor Cell Lymphoblastic Leukemia-Lymphoma 501Myeloproliferative Disorders 438Lymphoma, Non-Hodgkin 339Multiple Myeloma 327Hodgkin Disease 313Leukemia, Lymphocytic, Chronic, B-Cell 304Leukemia, Myelomonocytic, Chronic 299Primary Myelofibrosis 285Lymphoma 267Leukemia, Myeloid, Chronic-Phase 254Leukemia, Myeloid, Accelerated Phase 208Blast Crisis 208Lymphoma, Mantle-Cell 206Lymphoma, Follicular 204Burkitt Lymphoma 200Lymphoma, Large B-Cell, Diffuse 192Lymphoma, B-Cell, Marginal Zone 184Congenital Abnormalities 166Lymphoma, Large-Cell, Immunoblastic 165Polycythemia Vera 162Myelodysplastic-Myeloproliferative Diseases 159Neoplasms, Plasma Cell 152Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 145Anemia, Refractory, with Excess of Blasts 127Thrombocythemia, Essential 125Lymphoma, T-Cell, Cutaneous 124

Interventions

Mitoxantrone 1Epoetin Alfa 1Cytarabine 1Amifostine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Drug-Related Side Effects and Adverse Reactions × Myeloid × Clear all
NCT00003407 2023-02-02

Amifostine & High-Dose Combination Chemotherapy in Treating Patients With Acute ML or CML

Rush University Medical Center

Phase 2 Withdrawn
MyeloidOther hematologic neoplasm

Blast Crisis, Leukemia, Myelodysplastic Syndromes, Neutropenia, Leukemia, Myeloid, Acute, Drug-Related Side Effects and Adverse Reactions

NCT00003600 2016-07-13

Epoetin Alfa in Treating Anemia in Patients Who Are Receiving Chemotherapy

Alliance for Clinical Trials in Oncology

Phase 3 Completed
344 enrolled
BreastClassical hematologyLymphoidMyeloidOther hematologic neoplasmOther neoplasmPlasma cellThoracic

Anemia, Breast Neoplasms, Leukemia, Lung Neoplasms, Lymphoma, Multiple Myeloma, Myeloproliferative Disorders, Precancerous Conditions, Neoplasms, Plasma Cell, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡